RecruitingNCT06767605

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Registro Español de Enfermedades Hepáticas Colestásicas y Autoinmunes (ColHai)

Sponsor

Asociación Española para el Estudio del Hígado

Enrollment

5,000 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Primary Sclerosing Cholangitis (PSC)Primary Biliary Cholangitis (PBC)Hepatitis Autoimmune Disease Cholestatic Genetic Diseases

Summary

The purpose of the registry is to know the status of primary biliary colgantis, autoimmune hepatitis, primary sclerosing cholagitis and genetic cholestatic diseases in Spain.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cholestatic genetic diseases, hepatitis autoimmune disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Hospital Clinic

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06767605

Related Trials

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

NCT06016842186 locations

A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

NCT0730484340 locations